APLS - Apellis Pharmaceuticals Inc
IEX Last Trade
38.87
0.150 0.386%
Share volume: 636,076
Last Updated: Fri 30 Aug 2024 10:00:00 PM CEST
Research and Development in Biotechnology (except Nanobiotechnology):
0.21%
PREVIOUS CLOSE
CHG
CHG%
$38.72
0.15
0.39%
Summary score
23%
Profitability
25%
Dept financing
17%
Liquidity
50%
Performance
15%
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
Long-term ratios 30-Sep-2016 - 30-Sep-2020
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-67.07%
Return on assets
-19.34%
Return on sales
0%
Return on invested capital
286.37%
Total debt ratio
45.44%
Debt ratio change over timeo
-0.83%
Current Ratio
14.09%
Quick Ratio
0%
Cash Position Ratio
10.87%
Short-term ratios 30-Sep-2019 - 30-Sep-2020
The data are presented for the financials results of the quarters of the last year.
Return on equity
-143.82%
Return on assets
-17.92%
Return on sales
0%
Return on invested capital
320.37%
Total debt ratio
78.29%
Debt ratio change over timeo
-0.72%
Current Ratio
10.88%
Quick Ratio
0%
Cash Position Ratio
6.16%
Last quarter ratios 30-Sep-2020
The data are presented for the financials results of the last quarter.
Return on equity
-128.21%
Return on assets
-16.86%
Return on sales
0%
Return on invested capital
275.32%
Total debt ratio
86.22%
Debt ratio change over time
-0.7%
Current Ratio
9.86%
Quick Ratio
0%
Cash Position Ratio
5.54%
Performance ratios (change over 4 years) 30-Sep-2016 - 30-Sep-2020
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
-124.75%
Return on assets
-105.91%
Return on sales
0%
Return on invested capital
12.59%
Total debt ratio
-83.29%
Debt ratio change over time
-0.83%
Current Ratio
4.83%
Quick Ratio
0%
Cash Position Ratio
3.8%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | APLS | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | -67.07% | -3.65% | 12.3% | 6.42% |
| Return on assets | -19.34% | 3.5% | 3.6% | 5.35% |
| Return on sales | 0% | 31.31% | 41.82% | 33.97% |
| Return on invested capital | 286.37% | 4.99% | 7.81% | 13.62% |
| Profitability | 25% | 36% | 68% | 60% |
| Total debt ratio | 45.44% | 101.15% | 75.51% | 29.75% |
| Debt ratio change over time | -0.83% | 224.03% | 6.03% | 1.46% |
| Dept financing | 11% | 50% | 19% | 8% |
| Current Ratio | 10.88% | 2.03% | 1.87% | 3.47% |
| Quick Ratio | 0% | 1.9% | 1.53% | 2.82% |
| Cash Position Ratio | 6.16% | 1.41% | 0.73% | 1.41% |
| Liquididy | 50% | 15% | 33% | 33% |
| Short-term ratios | APLS | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | -143.82% | -16.17% | 18.05% | 7.63% |
| Return on assets | -17.92% | 2.71% | 3.58% | 5.03% |
| Return on sales | 0% | 29.9% | 36.22% | 35.56% |
| Return on invested capital | 320.37% | 6.54% | 5.97% | 19.39% |
| Profitability | 25% | 35% | 68% | 62% |
| Total debt ratio | 78.29% | 99.31% | 83.77% | 30.59% |
| Debt ratio change over time | -0.72% | 851.68% | 10.97% | 0.58% |
| Dept financing | 20% | 50% | 21% | 8% |
| Current Ratio | 10.88% | 2.03% | 1.87% | 3.47% |
| Quick Ratio | 0% | 1.9% | 1.53% | 2.82% |
| Cash Position Ratio | 6.16% | 1.41% | 0.73% | 1.41% |
| Liquididy | 50% | 27% | 21% | 39% |